FUTURE PERFECT INTERNATIONAL CONSULTING PTE. LTD.
UEN: 201734408N
FUTURE PERFECT INTERNATIONAL CONSULTING PTE. LTD.(201734408N) is a Singapore business with registered business address at 59 UBI AVENUE 1, 3-11, Singapore 408938. They specialise in the area of MANAGEMENT CONSULTANCY SERVICES (GENERAL).
| Company Name | FUTURE PERFECT INTERNATIONAL CONSULTING PTE. LTD. |
| Unique Entity Number | 201734408N |
| Entity Type | Local Company |
| Entity Status | Live Company |
| Incorporate Day | 29 November 2017 |
| Address |
59 UBI AVENUE 1 #3-11 Singapore 408938 |
| Products / Services | MANAGEMENT CONSULTANCY SERVICES (GENERAL) |
| Number of Officers | 3 |
| Paid Up Capital | SGD 120 |
Breaking! Business News
Car Brakes Winter Rust Prevention Guide by Goodyear Brakes ReleasedThe automotive experts at Goodyear Brakes offer some tips and solutions for assessing the health of ...
Read More
Vancouver’s Interior Designer and Feng Shui Expert’s Annual Webinar AnnouncedDJ Design Einstein Inc in Vancouver, Canada announces its full-day webinar featuring Feng Shui Maste...
Read More
ETC Sterilizers Awarded Multiple Contracts for EO Vacuum Chambers and Control Upgrades Totaling $3.1 MillionETC Sterilizers Awarded Multiple Contracts for EO Vacuum Chambers and Control Upgrades Totaling $3.1...
Read More
ETC Simulation Awarded Multiple Contracts for their Advanced Disaster Management Simulator (ADMS™) Totaling $2.8 MillionETC Simulation Awarded Multiple Contracts for their Advanced Disaster Management Simulator (ADMS™)...
Read More
Inflection Resources Engages Dr. Alan Wilson as Technical Advisor for Ongoing Copper-Gold Exploration Program in Northern New South WalesInflection Resources Engages Dr. Alan Wilson as Technical Advisor for Ongoing Copper-Gold Exploratio...
Read More
GreyOrange Appoints Ramya Sampath Sharma as Chief People OfficerGreyOrange Appoints Ramya Sampath Sharma as Chief People Officer-- Sharma leads human resources str...
Read More
Synchronoss Announces Appointment of Jeff Miller as Permanent CEO and PresidentSynchronoss Announces Appointment of Jeff Miller as Permanent CEO and PresidentGlobeNewswireMarch 08...
Read More
AIM ImmunoTech Announces First Healthy Subjects Dosed in Phase 1 Intranasal Ampligen Clinical StudyAIM ImmunoTech Announces First Healthy Subjects Dosed in Phase 1 Intranasal Ampligen Clinical StudyM...
Read More